Development of a general practice-based diagnostic asthma-risk index in young children: Reaping the benefits from an ongoing cohort study.

Development of a general practice-based diagnostic asthma-risk index in young children: Reaping the benefits from an ongoing cohort study. - ARCADE-II study (AiRway Complaints and Asthma DEvelopment in children)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30634

Enrollment

580

Registered

2007-03-01

Start date

2007-06-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma respiratory symptoms

Interventions

A lung function measurement and a metacholine challenge test will be performed in all 6-year old children with asthma-related complaints or on asthma medication use in the previous year. These measu

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: All children who do not reach the age of 6 during ARCADE (children who where included at age 1 to 3), will be asked to participate in ARCADE-II.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria beyond those in ARCADE. No new inclusions will occur, only follow-up.

Design outcomes

Primary

Measure	Time frame
The main outcomes in the study are: diagnosis of asthma (lung function test), quality of life, and severity of asthma (expressed in symptoms) at the age of 6. An asthma-risk index will be constructed for 1- to 3 year old children who visit the GP with complaints of recurrent coughing, wheezing or dyspnoea. In addition, we will determine which treatment strategy is most effective.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)